The development of methods for somatic gene therapy not only challenges the state-of-the-art of molecular biology, but also of surgery. In particular, the proposal that hepatic gene therapy could be performed by harvesting hepatocytes from a patient's genetically defective liver, infecting these cells with viruses carrying a recombinant gene capable of providing the defective gene product, and then returning these cells to the patient's liver is dependent upon the development of surgical techniques for hepatocellular transplantation. While there is an extensive surgical literature on hepatocellular transplantation in animals, this technique has never been attempted in humans. Hepatocellular transplantation would be useful not only as an adjunct procedure for somatic gene therapy, but may provide an attractive alternative to orthotopic liver transplantation in some patients with liver disease secondary to genetic abnormalities. In this proposal we describe experiments aimed at establishing methods for hepatocellular transplantation. We will evaluate optimal conditions for preservation of liver segments prior to hepatocyte isolation; conditions for handling and infusing hepatocytes; surgical approaches to delivering hepatocytes to the liver; and the optimal schedule for administration of hepatocytes.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Tarlow, Branden D; Pelz, Carl; Naugler, Willscott E et al. (2014) Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell 15:605-18
Wu, Y; Teng, B B; Brandt, M L et al. (1999) Normal perinatal rise in serum cholesterol is inhibited by hepatic delivery of adenoviral vector expressing apolipoprotein B mRNA editing enzyme (Apobec1) in rabbits. J Surg Res 85:148-57
Muzzin, P; Eisensmith, R C; Copeland, K C et al. (1997) Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats. Mol Endocrinol 11:833-7
Kuzmin, A I; Finegold, M J; Eisensmith, R C (1997) Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo. Gene Ther 4:309-16
Fang, B; Wang, H; Gordon, G et al. (1996) Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs. Gene Ther 3:217-22
Brandt, M L (1996) Gene therapy in pediatric surgery. Semin Pediatr Surg 5:197-205
Bowles, N E; Eisensmith, R C; Mohuiddin, R et al. (1996) A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo. Hum Gene Ther 7:1735-42
Brandt, M L; Eckert, J W; Buerkle, C J et al. (1996) The subcutaneous spleen: a new model for percutaneous access to the portal venous system. J Invest Surg 9:161-6
Eckert, J W; Buerkle, C J; Major, A M et al. (1995) In situ hybridization utilizing a Y chromosome DNA probe. Use as a cell marker for hepatocellular transplantation. Transplantation 59:109-11
Fang, B; Eisensmith, R C; Wang, H et al. (1995) Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum Gene Ther 6:1039-44

Showing the most recent 10 out of 25 publications